Alluvi Retatrutide 40mg injection pen

Name: Alluvi Retatrutide 40mg injection pen
Brand: MEDIWELL PHARMACEUTICALS
Price: 5000.0 INR
Availability: InStock

Price 5000.0 INR/ Box

Get a Price/Quote

MOQ : 10 Boxes

Alluvi Retatrutide 40mg injection pen Specification

Appearance
Pre-filled injection pen with clear labeling

Melting Point
Not applicable for injection solutions

Pacakaging (Quantity Per Box)
1 pre-filled pen (4 total doses per pen)

Dosage Guidelines
40 mg

Purity
Pharmaceutical Grade

Suitable For
Adult

Physical Form
Injection Pen

Solubility
In aqueous injection medium

Type
Other

Ingredients
Retatrutide in solution for subcutaneous injection

Feature
Ready-to-use pen for precise dosing, triple receptor activation

Shelf Life
3 Years

Storage Instructions
Store in a refrigerator (2C to 8C)

Indication
Designed to activate triple GIP, GLP-1, and glucagon receptors

Injection Route
Subcutaneous

Package Feature
Sterile, ready-to-administer, tamper-evident packaging

Instructions for Use
For subcutaneous use only, detailed instructions inside package

Brand Name
ALLUVI Retatrutide

Strength
40mg per pen (4 x 10mg doses)

Intended Patients
For use under prescription and medical supervision

Alluvi Retatrutide 40mg injection pen About

The Alluvi Retatrutide 40mg pen is an investigational triple-agonist research compound studied for obesity and metabolic research.

GLP-1 Receptors: Slows digestion down and lowers appetite.

GIP Receptors: Helps release insulin and process fat.

Glucagon Receptors: Boosts energy use and fat breakdown

Triple-Action Efficacy with ALLUVI Retatrutide

The ALLUVI Retatrutide 40mg injection pen stands out due to its unique mechanism of activating GIP, GLP-1, and glucagon receptors simultaneously. This triple receptor engagement supports improved therapeutic outcomes for eligible adults, as determined by a healthcare provider. The formulation promises precision and efficacy in every dose, adhering to high pharmaceutical-grade standards and regulatory requirements.

Convenient and Safe Administration

Designed for ease of use, the ALLUVI pen comes pre-filled and sterilized, ensuring safety from manufacture to administration. Its tamper-evident packaging and clear labeling assist both patients and healthcare providers in achieving accurate, secure, and hygienic subcutaneous injections. Detailed usage directions are included in every package for proper handling.

Storage and Shelf Life of ALLUVI Retatrutide

To maintain potency and quality, ALLUVI Retatrutide pens should be stored in a refrigerator at temperatures between 2C and 8C. The product has a shelf life of three years when managed under recommended storage conditions, making it suitable for clinics, hospitals, and pharmacies that demand reliability and consistency in medication supply.

FAQ's of Alluvi Retatrutide 40mg injection pen:

Q: How should the ALLUVI Retatrutide 40mg injection pen be administered?

A: The ALLUVI Retatrutide pen is designed for subcutaneous injection only. Detailed, step-by-step instructions are included inside the package to guide users through the proper administration process. Always use the pen as directed by a healthcare professional.

Q: What are the main benefits of ALLUVI Retatrutide?

A: ALLUVI Retatrutide offers triple-action efficacy by targeting GIP, GLP-1, and glucagon receptors. This can result in more comprehensive management of your condition, as prescribed by your doctor, and allows for precise, convenient dosing through a pre-filled pen.

Q: When and how often should I use the ALLUVI Retatrutide pen?

A: Dosage and frequency should be determined by your healthcare provider. Each pen contains four 10mg doses, totaling 40mg per pen. Always follow your prescriber's instructions for dosing and scheduling.

Q: Where should I store ALLUVI Retatrutide pens?

A: Store the ALLUVI Retatrutide pen in a refrigerator at 2C to 8C. Do not freeze. Keep the pen in its original, tamper-evident packaging until ready for use, and always keep it out of reach of children.

Q: What makes ALLUVI Retatrutide's packaging secure and user-friendly?

A: The pen is supplied in sterile, pre-filled, tamper-evident packaging with clear labeling. This ensures product integrity from distribution to administration and helps users achieve correct dosing safely and conveniently.

Q: Who is ALLUVI Retatrutide intended for?

A: This medication is intended for adult patients who have been prescribed retatrutide by a qualified healthcare professional. It must be used under prescription and medical supervision.

Q: What should I do if I have questions about dosing or experience side effects?

A: Contact your prescribing healthcare provider immediately if you are unsure about dosage or experience any unusual reactions or side effects. Never attempt to adjust your dose without professional guidance.

Tell us about your requirement